ULM Ltd Competitors

NextPhase Medical Devices is the leading low- to medium- volume outsource partner for complex Electronic Manufacturing Systems (EMS) and disposable medical devices in North America. In July 2017, Nexcore Technology, LLC acquired Phase 2 Medical Device Manufacturing, Inc. From this acquisition, NextPhase Medical Devices LLC was launched. This combination has produced a unique company that has a proven track record with medical device OEMs requiring a full-service contract manufacturing partner. Headquartered in Mansfield, MA with locations in Rochester, NH and Tijuana, Mexico, we are proud and honored to be able to provide medical device design, development, manufacturing and assembly solutions that have a positive impact on the lives of patients. At NextPhase we have well-trained customer-centric teams with extensive medical industry knowledge and the drive to deliver the highest quality medical device design, development, manufacturing, and assembly services available. Our more than forty years of collective experience have earned us numerous industry awards, including Medical Design Excellence awards. We’re proud to have a range of customers spanning from start-ups to multinational OEMs. For a list of open job positions, please visit our career web page: https://nextphasemed.com/careers/

CORE Health Care, located between Austin and San Antonio, TX, offers post-acute rehabilitation and long-term care for people with brain injuries, psychiatric disorders, autism or other special needs. Licensed professionals provide physical, occupational, speech, vision, cognitive and psychotherapy. Staying on the cutting edge of new research, CORE provides the most effective treatment with neuroplasticity as the guiding philosophy for individualized care. Our goal is to restore self-directed functional ability to ensure a minimal need for support services. To offer comfort and safety, we have private rooms and a low staff to client ratio. CORE is accredited by CARF, contracted with DARS and most major insurances. We have successfully provided care for over 25 years.

Pathway Medical Technologies, Inc. was founded to design, market and manufacture medical devices for the treatment of arterial disease. The company's initial focus is treating peripheral arterial disease (PAD) more quickly and effectively than existing technologies. An estimated 12 million people are afflicted by PAD in the U.S. and that number is projected to grow to over 20 million during the next 10 years. The company's Jetstream™ device allows for a minimally invasive procedure designed to restore circulation in the peripheral arteries by removing both hard and soft diseased tissue.